On 1 January 2017, the US section 871(m) regulations entered into force. The 871(m) regime aims to regulate derivative instruments, for example, futures, forwards, total return swaps, equity securities lending and repurchase agreements, referencing US equities, regardless of the location of the issuer.
The goal of 871(m) is to ensure that such instruments are not being used by non-US persons to enjoy the benefits of holding the underlying US equity, while avoiding US withholding tax. In order to address this, 871(m) introduces the concept of a deemed dividend on behalf of these instruments whenever a dividend is paid on the referenced underlying US equity. These deemed dividend payments, so-called dividend equivalent payments, are treated by the IRS as US source income, subject to withholding and reporting that is consistent with treatment when holding US equities directly and receiving dividend payments. As the location of the issuer is not relevant under 871(m), a Swiss structured product referencing a US equity, held through a Swiss custodian and with a Swiss investor can fall within the scope of 871(m). Thus, such Swiss structured product could potentially pay dividend equivalents subject to US withholding tax and reporting.
To reduce the impact of 871(m), the IRS introduced a new status available to eligible financial institutions involved with the issuance of derivative instruments. Available as part of the QI regime, the qualified derivatives dealer (QDD) status simplifies the withholding process for affected instruments and in return imposes enhanced due diligence and reporting requirements on QDDs, similar to the ones imposed to QIs.
Due to its complexity, the 871(m) regime has not yet been fully implemented and is being phased in with the full scope not taking effect until 31 December 2022. During this phase-in period, various elements of the regulations are not yet applicable and the scope of impacted instruments is limited to delta-one instruments. Despite this phased-in implementation timeline and the current relief, a financial institution that issues or acts in an intermediary capacity with respect to derivative products, must still ensure compliance with the current regulations and prepare for what might be coming in the future.